Your institution may have access to this item. Find your institution then sign in to continue.
Title
Vandetanib Versus Placebo in Patients With Advanced Non-Small-Cell Lung Cancer After Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor: A Randomized, Double-Blind Phase III Trial (ZEPHYR).
Authors
Jin Soo Lee; Hirsh, Vera; Park, Keunchil; Shukui Qin; Blajman, Cesar R.; Reury-Perng Perng; Yuh-Min Chen; Emerson, Laura; Langmuir, Peter; Manegold, Christian
Publication
Journal of Clinical Oncology, 2012, Vol 30, Issue 10, p1114